AizenPower VSL ãšåºååæ
ãã®ãããªã¯äººçš®çã¹ãã¬ãªã¿ã€ãã§å§ãŸãããã®çŽåŸã«å転ãããŸããAizenPower ã®ã»ãŒã«ã¹ã¬ã¿ãŒã®ãã¬ãŒã¿ãŒã¯ãæåã® 10 ç§ä»¥å ã«ãèª¬åŸæã®æãå€ãææ³ã® 1 ã€ã§ããâŠ
Restricted Access
+2,000 VSLs & Ads Scaling Now
+50â100 Fresh Daily · 34+ Niches · Personalized S.P.Y. · $29.90/mo
ã¯ããã«
ãã®ãããªã¯äººçš®çã¹ãã¬ãªã¿ã€ãã§å§ãŸãããã®çŽåŸã«å転ãããŸããAizenPower ã®ã»ãŒã«ã¹ã¬ã¿ãŒã®ãã¬ãŒã¿ãŒã¯ãæåã® 10 ç§ä»¥å ã«ãèª¬åŸæã«ãããæãå€ãææ³ã® 1 ã€ããã¿ãŒã³ã€ã³ã¿ã©ããããå®è¡ããŠããŸããã¢ãžã¢ç³»ç·æ§ã®è§£ååŠã«é¢ããåºãä¿æãããä»®å®ãåŒãåºãããã®çå®ã¯ãè¡æçã§ããããšçºè¡šããããšã§ãVSL ã¯èŠèŽè ã®èªç¥ç解決ã®å¿ èŠæ§ãæªçšããŸããäºæããªãççŸã«çŽé¢ããè³ã¯ãåŠçãç¶ããããšãäœåãªããããŸãããã®åŸã® 30 å以äžã«ããã£ãŠå±éããã®ã¯ãæ¥ãå¹»æ³ãç°åœçæš©åšãç䌌ç§åŠãããã³ç·è¿«æã®æ éã«æ§æãããã·ãŒã±ã³ã¹ã§ãããæ°å幎ã®ãã€ã¬ã¯ã ã¬ã¹ãã³ã¹ ã³ããŒã©ã€ãã£ã³ã°ã®æ £äŸãå©çšããªãããæ¶è²»è å¥åº·ã«ãããæãæ³çããã³å«ççã«å±éºãªãããã® 1 ã€ã§ããããã¹æ¡å€§ã®äžã§å±éããããããã¢ãŒããã¯ãã£ã§ãã
ãã®åæã¯ãããŒã±ãã£ã³ã° ã¢ãŒãã£ãã¡ã¯ããšããŠã® AizenPower VSL ãæ€èšŒããŸãããã®è£œåã¯ãäž»ã«ãã®é·ç·šãããªãã¬ãŒã³ããŒã·ã§ã³ãéããŠãªã³ã©ã€ã³ã§è²©å£²ãããé£äºãµããªã¡ã³ãã§ãããããã¹ã®ãµã€ãºãåèµ·æ©èœãããã³æ§çèªä¿¡ã«ã€ããŠèŠçãçµéšããŠããç·æ§ãã¿ãŒã²ããã«ããŠããŸãããã®ããããã©ã®ããã«æ©èœããããã©ã®å¿ççã¬ããŒãåŒãããã©ã®ç§åŠç䞻匵ãè¡ããããããŠãããã®äž»åŒµã粟æ»ã«èãããã©ãããçè§£ããããšã¯ã補åã調æ»ããŠããæ¶è²»è ãšããèŠå¶ãããå¥åº·äž»åŒµã®ç«¯ã§èª¬åŸãã©ã®ããã«æ©èœããããç ç©¶ããŠããããŒã±ã¿ãŒã«ãšã£ãŠãæçšã§ããVSL ã¯ããããã尺床ã§ãæè¡çã«æŽç·Žããããã€ã¬ã¯ã ã¬ã¹ãã³ã¹ ã³ããŒã§ãããã®èåŸã«ãã補åããã®æŽç·ŽããšäžèŽãããã©ããã¯ããŸã£ããå¥ã®åé¡ã§ãã
ãã¬ãŒã¿ãŒã¯èªåèªèº«ããå»åŠç ç©¶å°éå®¶ã®ã¢ãŒãã«ã P. ãžã§ã€ã¹ããšç¹å®ããã¬ã¿ãŒãè±éã®æ ãšããŠæ§æããŠããŸãïŒè·æ¥çå±èŸ±ãšå人çãªæ¥ãããæ±åã¢ãžã¢ã§ã®ç°åœçãªçºèŠãéããŠãããã¹ã®æé·ã®ããã®æœåšçãªéºäŒåã¹ã€ãããèµ·åãããšäž»åŒµããããµããªã¡ã³ãã®çºæãŸã§ãã¹ããŒãªãŒããªã³ã°ã¯ææ çã«æ²¡å ¥åã«ãªãããã«èšèšãããŠããã30 ã 60 æ³ã®ç¹å®ã®èŠèŽè ïŒæ§çããã©ãŒãã³ã¹ã«ã€ããŠæ¥ãå åšåããç·æ§ïŒã«ãšã£ãŠã¯ãããããããã§ãããã®ããŒã¹ã調æ»ããåé¡ã¯ç°¡æœã§ãïŒAizenPower ã®ãããã¯å®éã«ã©ã®ãããªäž»åŒµãããã®ãã説åŸã·ã¹ãã ãšããŠã©ã®ããã«æ©èœããã®ãããããŠãããåŒãåºãæåãšã¡ã«ããºã ã«ã€ããŠå©çšå¯èœãªç§åŠã¯äœãèšã£ãŠããã®ãã
AizenPower ãšã¯äœãïŒ
AizenPower ã¯ãããã¹ã®ãµã€ãºãå¢å ãããåèµ·æ©èœãæ¹åãããªãããŒãšã¹ã¿ãããå¢åŒ·ããããšèããŠããç·æ§ã«ç¹ã«è²©å£²ãããçµå£é£äºãµããªã¡ã³ãã§ãã補åã¯ç¬èªã®ã»ãŒã«ã¹ããŒãžãéããŠã®ã¿è²©å£²ãããVSL 㯠AmazonãeBayããŸãã¯ãã®ä»ã®ãµãŒãããŒãã£ã®å°å£²æ¥è ã§ã¯å©çšã§ããªãããšãæç¢ºã«è¿°ã¹ãŠãããæè¡ãããã¹ãã³ããããã³å»åŠçåèµ·äžå šæ²»çãžã®èªç¶ã§é䟵襲çãªä»£æ¿ææ®µãšããŠäœçœ®ä»ããããŠããŸãããã®åœ¢åŒã¯ 1 æ¥ 2 åæåãããæ¯æ¥ã®ãµããªã¡ã³ãã§ããããã¬ãŒã¿ãŒãã¿ã€ã®ååŒçãªããŒã·ã§ã³ãããªããŒã¹ãšã³ãžãã¢ãªã³ã°ãããšäž»åŒµããæ€ç©æœåºç©ãé žãããã³åŸ®éããã©ã«ã®ãã¬ã³ããã補é ãããŠããŸãã
åžå Žããžã·ã§ãã³ã°ã®ç¹ã§ã¯ãAizenPower ã¯ç·æ§ã®æ§çå¥åº·ãµããªã¡ã³ã ã«ããŽãªãŒã®æãç©æ¥µçãªç«¯ã«äœçœ®ããŠããŸãããã®ã¹ããŒã¹ã®äž»æµãã©ã³ãïŒãã¹ãã¹ããã³ããŒã¹ã¿ãŒãŸãã¯äžé žåçªçŽ ãµããªã¡ã³ããèããŠãã ããïŒããå¥åº·ãªæ§çæ©èœããµããŒããããããšã«ã€ããŠæ éã§ FTC ã«æºæ ãã䞻匵ãããŠããå ŽåãAizenPower VSL ã¯æ°žç¶çãªè§£ååŠçå€åãæç¢ºã«çŽæããŸããå ·äœçã«ã¯ãéºäŒç掻æ§åãéãã 3 ã 7 ã€ã³ã以äžã®é·ãã®å¢å ã§ããããã¯ä¿¡é Œã§ããç§åŠçæ¯æŽããªã䞻匵ã§ãããFDA ãå«ãèŠå¶æ©é¢ãæŽå²çã«ç²Ÿæ»ããŠãã補åã®ã«ããŽãªãŒã« AizenPower ã眮ããŸãã衚瀺ãããŠããã¿ãŒã²ãã ãŠãŒã¶ãŒã¯ãããã¹ã®ãµã€ãºãŸãã¯æ§çããã©ãŒãã³ã¹ã«äžæºã®ããä»»æã®å¹Žéœ¢ãäœéããŸãã¯å¥åº·ç¶æ ã®æäººç·æ§ã§ãã
補åã¯ããã¬ãŒã¿ãŒèªèº«ã«ãã£ãŠéçºãããèšåºæ£è ã§ãã¹ããããã¢ãªãŸãã®å°ããªããã¡ãªãã·ãŒæœèšãã«ãã£ãŠè£œé ããããã®ãšããŠæç€ºãããŠããŸãããµããªã¡ã³ãã®éå»åŠçåé¡ãšçµã¿åããã詳现ã¯ãèšåºè©ŠéšèŠä»¶ãªãã§ãããåžå Žã«å°éããæ¹æ³ã説æããŠããŸããããã¯æ é€è£å©é£åæ¥çã®äžè¬çãªæ§é äžã®ç¹åŸŽã§ããç±³åœã®é£äºãµããªã¡ã³ã㯠1994 幎é£äºè£å©é£åå¥åº·æè²æ³ïŒDSHEAïŒã®äžã§èŠå¶ãããŠãããããè£œé æ¥è ã¯è²©å£²åã«æå¹æ§ã蚌æããå¿ èŠã¯ãªãã補åãå®å šã§ãªãããšã確èªããã ãã§æžã¿ãŸãã
ããã察象ãšããåé¡
AizenPower ã察象ãšããåé¡ã¯å®åšããŠãããããšãææ¡ããããœãªã¥ãŒã·ã§ã³ã¯ååšããªããŠããããã¹ã®ãµã€ãºã«é¢é£ãã身äœã€ã¡ãŒãžã®èŠçã¯ã枬å®å¯èœãªèšåºççµæãæã€èšé²ãããå¿çççŸè±¡ã§ããBritish Journal of Urology International ã«æ²èŒãããç ç©¶ã§ã¯ããå°ããããã¹ãã®æžå¿µã«ã€ããŠæè¡çãŸãã¯å»åŠççžè«ãæ±ããç·æ§ã®çžåœãªå²åããæ£åžžãªç¯å²å ã«ããçæ®åšãæã£ãŠããããšã倿ããŠããŸããèšåºå»ãæã ããã¹å€åæ§é害ãšããŠèª¬æããç¶æ ã¯ãæ§é çã«èº«äœé圢é害ã«é¡äŒŒããŠããŸãããã®èŠçã®å¿ççè² æ ãæ§çç¶æ³ã§ã®äžå®ã芪å¯ãã®åé¿ãé¢ä¿ã®æçµ¶ã¯æ¬ç©ã§ãããVSL ã®ç©èªã¯ãããäžå®ãªã»ã©ã®æ£ç¢ºãã§åæ ããŠããŸãã説æãããŠããã·ããªãªïŒå ¬å ±ã®ã·ã£ã¯ãŒã§é ããããšãããŒãããŒã®å€±æãã衚çŸãèŠãããšãçµå©ã倱ãããšïŒã¯ãçºæããããã®ã§ã¯ãªããå®åšããããã ãååãªãµãŒãã¹ãåããŠããªãéå£ã®çããçµéšã§ãã
忥æ©äŒã¯å¯Ÿå¿ããŠå€§ããã§ããã°ããŒãã«ãªç·æ§ã®æ§çå¥åº·ãµããªã¡ã³ãåžå Žã¯ãæè¿ã®æ¥çæšå®ã§ã¯ 25 åãã«ãè¶ ãã䟡å€ããããŸãããåèµ·äžå šãšããã©ãŒãã³ã¹äžå®ãæ¶è²»è æ¯åºã®äž»ãªæšé²åã§ããVSL ã¯ç¹ã«ãåŸæ¥ã®å»åŠã解決ã«å€±æããããç©æ¥µçã«éžæããªãã£ãããããã®åé¡ãšããŠåé¡ããã¬ãŒãã³ã°ãã54 åãã«ã®å»åŠå»çç£æ¥ããç·æ§ãäžååãªç¶æ ã«ä¿ã€ããšã§å©çãåŸãæµãšããŠäœçœ®ä»ããŸãããã®ãã¬ãŒãã³ã°ã¯çå®ã®æ žãå«ãã§ãããã广çã§ãïŒå€ãã®ç·æ§ã¯ããµã€ãºã«ã€ããŠæžå¿µãæèµ·ããæã«ãèšåºå»ããç¡èŠãããŠãããšæããŠããŸãããŸããå»åŠå»çç£æ¥ã¯ãã©ã€ãã¹ã¿ã€ã«ãŸãã¯ãµããªã¡ã³ãä»£æ¿æ¡ãããåŠæ¹æ²»çãä¿é²ããããã®çµæžçã€ã³ã»ã³ãã£ãããããŸããVSL ã¯ãã®æ žãåãããããå®å šãªé°è¬è«ã«èšããŸããŸãã
éèŠãªããšã«ãVSL ã¯ãŸãç§åŠçãªç¥èŠãå°å ¥ãããã®åŸè§£äœããããã«èŠããŸããããã¹ã®ãµã€ãºã¯éºäŒçã«æ±ºå®ããããšããç¥èŠã倧éªã®ãããã³ãã£ã¢ãã€ãªãµã€ãšã³ã¹ã¹ã¯ãŒã«ãããã® SRY éºäŒåã«é¢ããç ç©¶ãåŒçšããåŸããã®éºäŒåã¯é©åãªæ€ç©ååç©ã§ç¡å¹ã«ããããšãã§ãããšäž»åŒµãçŽã¡ã«åãæ¿ããŸãããã㯠false bottom ãšããŠç¥ãããã¬ããªãã¯æ§é ã§ãããã¬ãŒã¿ãŒã¯ãæçµçã§çµ¶æçãªçå®ã®ããã«èŠãããã®ã確ç«ãããã®åŸãç§å¯ã®åºå£ãæããã«ããŸããããã¯é·ç·šãã€ã¬ã¯ã ã¬ã¹ãã³ã¹ã§æãææ çã«åŒ·åãªåãã® 1 ã€ã§ãããªããªããææžãå°çããåã«ãèªè ã«çµ¶æã®å®å šãªçµéšã匷å¶ããããã§ãããã®æç¹ãŸã§ã«ããã®è§£æ±ºçãžã®ææ çãªæè³ã¯æå€§åãããŸãã
CDC ãš WHO ã¯ããããã¹ã®äžå®ããå ¬è¡è¡çã®æžå¿µãšããŠç¹ã«è¿œè·¡ããŠããŸããããVSL ãèŠæš¡æžå¿µãšçµã¿åãããŠããåèµ·äžå šã¯ãNational Institute of Diabetes and Digestive and Kidney DiseasesïŒNIDDKïŒããã®ããŒã¿ã«ãããšãç±³åœã ãã§æšå® 3000äžäººã®ç·æ§ ã«åœ±é¿ãäžããŸããããã¯ãäžè¬çãªãµã€ãºé¢é£ã®èªå·±æèãèšåºç㪠ED 蚺æãªãã§çµéšããç·æ§ã®åºã人å£ã説æããåã§ãã£ãŠãããããã«çµ±èšçã«å·šå€§ãªæœåšçèŠèŽè ãäžããŸãã
ä»ã® VSL ããã®ãããã§ã©ã®ããã«ããããæ§æããŠãããèå³ããããŸããïŒ èªã¿ç¶ããŠãã ãããã»ã¯ã·ã§ã³ 7 ã§ã¯ãäžèšã®ãã¹ãŠã®äž»åŒµã®èåŸã«ããå¿çåŠãåæããŠããŸãã
AizenPower ã¯ã©ã®ããã«æ©èœããã
AizenPower ã®äž»åŒµãããã¡ã«ããºã ã¯ãVSL ããããã¹æé·éºäŒåããšåŒã¶ãã®ã®åšãã«æ§ç¯ãããŠããŸããSRY éºäŒåãšããŠèå¥ãããããã¯ç·æ§ã®æ§ç決å®ãšçºå±ã«é¢äžããå®éºäŒåã§ããSRY éºäŒåã¯ç¢ºãã«ç§åŠçç ç©¶ã®åæ³çãªå¯Ÿè±¡ã§ããããã¯èå çºéäžã«ç·æ§ã®æ§çååãåŒãèµ·ãã転åå åãã³ãŒãããŸãããããããã®éºäŒåã¯æäººç·æ§ã®æ€ç©ååç©ã«ãã£ãŠãç®èŠãããããããæ°ããããã¹çµç¹ãçæã§ãããšãã VSL ã®äž»åŒµã¯ãå ¬è¡šããã忥è ã«ããã¬ãã¥ãŒãããç ç©¶ã«ãã£ãŠãµããŒããããŠããŸãããSRY éºäŒåã®çæ®åšçºéã«ããã圹å²ã¯åºçåã§ããæäººæä»£ãå°çãããã£ãšåã«éãŸãéèŠãªçºéãŠã£ã³ããŠäžã«åäœããŸããé£äºãµããªã¡ã³ããèå éºäŒåçºçŸãåã³æŽ»æ§åããŠæäººè§£ååŠçæé·ãçæã§ãããšããä¿¡é Œã§ããã¡ã«ããºã ã¯ååšããŸããã
ãã¬ãŒã¿ãŒã説æãã 4 段éã®ã¡ã«ããºã ïŒéºäŒåãç®èŠããããçµç¹ãã«ããŒãåºæ¿ããè¡æµãæ¹åãããªãããŒãä¿é²ãããšããã®ã¯ãåæ³çãªçç©åŠçèªåœïŒéºäŒåçºçŸãã¢ããé žãè¡ç®¡æ¡åŒµãçµç¹åçïŒãåããã¬ããªãã¯çã«æŽç·Žãããã¹ãã£ãã©ãŒã«ãã£ã³ã°ã§ããæ¥ç¶ç§åŠãªããããšãã°ãã¢ã«ãã¡ãªãé žã¯ãé žåã¹ãã¬ã¹ã«å¯Ÿãã广ã«é¢ããçã®ç ç©¶ãæã€å®åšããæé žåç©è³ªã§ãããŸããããã€ãã®ç ç©¶ã§ã¯ãåèµ·æ©èœã§ããã¬ã¹ãã©ãããŒã«ã¯ãå¿è¡ç®¡å©çã«é¢ããå ¬è¡šãããããŒã¿ãæã£ãŠããŸããè¡ç®¡æ¡åŒµãå«ã¿ãŸããæé®®äººåã¯ãåèµ·æ©èœã®æ§ãããªæ¹åã®ããã®æå³ã®ãã蚌æ ããŒã¹ãæã£ãŠããŸãããããã¯çã®æåã§ããå®ãå¶éããã广ãæã€ãã®ã§ããããããã®èª°ã SRY éºäŒåã«äœçšããã誰ããæ°ããããã¹çµç¹ãçæãã誰ã VSL ãçŽæãã 3 ã 7 ã€ã³ãã®å¢å ãçæããŸããã
ãµããªã¡ã³ãã劥åœã«è¡ããå¯èœæ§ãããã®ã¯ããã®æåãªã¹ããæ£ç¢ºã§ãããæäžéãååã§ããéããäžè¬çãªè¡ç®¡ã®å¥åº·ããµããŒãããè¡æµã®ããããªæ¹åãè¡ãããšã§ããããã¯ãåèµ·äžå šãäž»ã«è¡ç®¡ã§ããç·æ§ã«ãããåèµ·ã®è³ªã«äºæ¬¡çãªå©çãæã€ããšãã§ããŸããããã¯ãäœå°è«æ±ã®äžã«é ããŠããæ£åœãªããŒãžã§ã³ã®ãããã§ããåºå¥ã¯éåžžã«å€§ããªæå³ãæã£ãŠããŸãïŒãå¥åº·ãªåèµ·æ©èœããµããŒãããå¯èœæ§ããããŸãããšãããã¹æé·éºäŒåãæŽ»æ§åãã7 ã€ã³ãã远å ããŸããã¯åãè«æ±ã®å€åã§ã¯ãããŸããããããã¯ã«ããŽãªãŒå¥ã«ç°ãªãã¢ãµãŒã·ã§ã³ã§ããããã®ãã¡ 1 ã€ã ããç§åŠçæ ¹æ ãæã£ãŠããŸããVSL ã¯å®å šã« 2 çªç®ã«åºã¥ããŠæ§ç¯ãããŠããŸãã
ç°åœçãªèµ·æºç©èªãã¿ã€ã®å¯ºé¢ãååŒçãªããŒã·ã§ã³ãç§å¯ã®ã¢ãžã¢ã®å åŒå£ã¯ãã¡ã«ããºã ã§ã¯ãªã æš©åšè»¢é ãšããŠæ©èœããŸããå€ä»£ã§ãã¹ããããäŒçµ±ã«åŒãæ¥å°ããããšã«ããããã¬ãŒã¿ãŒã¯èšåºèšŒæ ã®èŠæ±ãåé¿ããŸããããã¯ä»£æ¿å»çããŒã±ãã£ã³ã°ã§äœ¿ãå€ãããåãã§ãã人é¡åŠçãªç¥ç§äž»çŸ©ã¯ãã©ã³ãã 忝èŒè©Šéšã®ä»£ãããããŸãããã¬ãŒã¿ãŒããã®åŸãåŒãå®éšå®€åæã®å¯Ÿè±¡ã«ãããšäž»åŒµããŠãããšããäºå®ã¯ãäŒçµ±çãªæš©åšãç§åŠçæš©åšãšèåãããããšãæå³ããŠãããããããã®ãœãŒã¹ãåç¬ã§æäŸãããããå€ãã®ãã€ããªããä¿¡é Œæ§ãçæããŸãã
äž»ãªæåãšã³ã³ããŒãã³ã
AizenPower ã®åŒã¯ãVSL ã§èª¬æãããŠããããã«ã 11 ã®äž»èŠãªæåãå©çšããŠããŸãããã¬ãŒãã³ã°ã¯ãããããçãããç¹å®ã®å°ççå°åãã調éãããçµã¿åããã§ãŠããŒã¯ã«å¹æçã§ããããšã瀺ããŠããŸãã以äžã¯ãå ¬éãããŠããç§åŠã«å¯Ÿããããããã®æåã®è©äŸ¡ã§ãã
Asian Gold ThreadïŒCoptis chinensisããã«ããªã³æºïŒïŒ äŒçµ±çãªäžåœå»åŠæ€ç©ã§ããã®æŽ»æ§ååç©ãã«ããªã³ã¯ã代è¬ããã³å¿è¡ç®¡å©çã®ããã®çã®ç ç©¶æ¯æŽãæã£ãŠããŸããããã€ãã®ç ç©¶ã§ã¯ããã«ããªã³ãå ç®æ©èœãæ¹åããå¯èœæ§ããããããã¯éæ¥çã«åèµ·ã®å¥åº·ã«å©çãããããå¯èœæ§ããããŸãããããã¹æé·éºäŒåãå«ã现èã«çµåããŠããããåèµ·åãããšãã䞻匵ã¯ãå ¬è¡šãããç ç©¶ã«ãã£ãŠãµããŒããããŠããŸããã
Crepe Myrtle / Pride of IndiaïŒLagerstroemia speciosaïŒïŒ ã³ããœã«é žãå«ãã§ããŸããããã¯ãè¡ç³èª¿æŽã«ã€ããŠç ç©¶ãããŠããŸãããååŸã§ããæåŒ·ã®æé žåç©è³ªããšããŠã®èå¥ã¯ã蚌æ ãããªãèªåŒµããŠããŸããããŒã©ãŽã¡ãŒã仿ãšã«ãã¹ãŒãã©ã®ããã¹ããžã®åç §ã¯ãç§åŠçãªæ¿èªã§ã¯ãªããæåçãªè£ 食ã§ãã
Corosolic Acid: Lagerstroemia speciosa ã®èããæœåºããããã®ååç©ã¯ã€ã³ã¹ãªã³æåºŠæ¹åã®ããã®æ§ãããªèšŒæ ãæã£ãŠããŸãããããã¹æé·éºäŒåã®ã·ãŒã«ãããšããŠã®äž»åŒµããã圹å²ã¯ãç§åŠçæ ¹æ ããããŸããã
Alpha Lipoic AcidïŒALAïŒ: ããç ç©¶ãããŠããæé žåç©è³ªã§ãããé žåã¹ãã¬ã¹ã«å¯Ÿããå®èšŒããã广ãšãç¥çµé害æ§çç¶ã®åæžã«å¯Ÿãã蚌æ ãæã£ãŠããŸããAsian Journal of Andrology ã«æ²èŒãããããç ç©¶ã¯ãç·æ§ã®æ§çæ©èœã«é¢é£ãã ALA ã調ã¹ãŠããŸããã調æ»çµæã¯äºåçã§ãããED ã®æ²»çã§ 90% ã®æåçãã¯ããMedicine Journalãã¯ãäžãããã説æããæ€èšŒããããšã¯ã§ããŸããã
TenchaïŒé°å¹²ãæ¹è¶ã®åé§äœïŒ: é°å¹²ãæ œå¹æ £è¡ã«ãããå¡©çŽ ãšã¢ããé žå«æéãäžæããæ¬ç©ã®ãè¶è£œåãç·è¶ã®ã«ããã³ãšããªãã§ããŒã«ã¯ãæç®ã®å¿è¡ç®¡å©çãæã£ãŠããŸããåèµ·ã«é¢é£ããäžé žåçªçŽ çç£ãå«ããçµç¹ãã«ããŒã®çç£é床ã 2 åã«ãããšããç¹å®ã®è«æ±ã¯ãµããŒããããŠããŸããã
Resveratrol: åŒã§ãã培åºçã«ç ç©¶ãããŠããæåã® 1 ã€ãããŒããŒãå»åŠéšã®ç ç©¶è ã«ãã SIRT1 çµè·¯ã«é¢ããç ç©¶ãå«ãå ¬è¡šãããç ç©¶ã¯ãè¡ç®¡æ¡åŒµãå«ãå¿è¡ç®¡å¹æã®ããã®ã¬ã¹ãã©ãããŒã«ã確èªããŠããŸããã0.39 ã€ã³ã Yantai ã°ã¬ãŒããã®ä»æ§ãææçŸ©ã§ããããå®è£ ããŒã±ãã£ã³ã°ã·ã¢ã¿ãŒã§ããããè©äŸ¡ããããšã¯ãå®éã®è£œååŒãªãã«äžå¯èœã§ãã
Milk ThistleïŒã·ãªããªã³ïŒ: èèä¿è·ç¹æ§ãšæé žåç¹æ§ãæã€ç¢ºç«ãããååç©ããã®äž»ãªèšŒæ ããŒã¹ã¯ãèèã®å¥åº·ã§ãããæ§çæ©èœãè¡ççç£ã§ã¯ãããŸããããæçµããã¹ãããã¯ã¹ãã®æå®ã¯ãç§åŠçã§ã¯ãªãåµé çã§ãã
Cayenne PepperïŒã«ããµã€ã·ã³æºïŒ: ã«ããµã€ã·ã³ã¯ãäžæçãªå容äœå¯èœãªãã£ãã«ïŒTRPïŒãã£ãã«ã®æŽ»æ§åãéããŠåŸªç°ãæ¹åããããã®èšŒæ ãæã£ãŠããŸããæ§ãããªè¡æµå©çã¯åŠ¥åœã§ãããé·ã倪ãèµ€ããšããŠã®è£œååºæã®åœåã¯ãåç²§ã§ã¯ãªããå¥ã®æ€ç©åé¡ã§ãã
Korean Ginseng RootïŒPanax ginsengïŒ: ããã¯ããã®åŒã§æã匷ãç¬ç«ãã蚌æ ããŒã¹ãæã€æåã§ããJournal of Urology ã«æ²èŒãããç ç©¶ããã㯠900mg 3 åã® 1 æ¥ 3 åã®ç·éã§ 18 é±éã«ããã 45 ã® ED æ£è ã調ã¹ã de Andrade et al. ã«å¯Ÿå¿ãã 2002 幎ã®ç ç©¶ã®ããã§ããåèµ·ã®ç¡¬ããšè³ªã®æ¹åãå ±åããŸãããããã¯ãVSL ã®åŒçšãããŠããç ç©¶ãå®åšããå ¬è¡šãããç ç©¶ã«å¯Ÿå¿ããããã«èŠããæ°å°ãªããã€ã³ãã® 1 ã€ã§ãã
ZincïŒ11mgïŒ: 粟åã®çç£ã«ãããäºéã®åœ¹å²ã¯ç¢ºç«ãããŠããŸããNutritionïŒPrasad et al.ã1996ïŒã®ç ç©¶ã§ã¯ãæ¬ ä¹çã®ããç·æ§ã®äºéè£å ã¯ç²Ÿåã¬ãã«ãå€§å¹ ã«å¢å ãããããšã瀺ãããŸãããåŒçšããã 11mg ã®çšéã¯ãæ¯æ¥ã®åç §å€ã«è¿ãããããçççã«åŠ¥åœãªå«æç©ã«ããŸãã
Chromium: ã¯ãã ã®ç²Ÿåä¿é²å¹æã«é¢ãã蚌æ ã¯åŒ±ããæç®ã§ã¯äºãããŠããŸããäœéæžå°ãšãŒãžã§ã³ããšããŠã®å«æç©ã¯ãã€ã³ã¹ãªã³æåºŠã«é¢ããç ç©¶ã«ãã£ãŠãµããŒããããŠããŸãããå¹æã¯æ§ããã§ãã
ãã㯠ãšåºåã¢ã³ã°ã«
ãªãŒããã³ã° ããã¯ããããã¹ã 12 ã€ã³ãã»ã©å°ããã¢ãžã¢ç³»ç·æ§ãç§ãæ³åããããšã®ãªãããšãã¯ã3 ã€ã®ããšãåæã«è¡ãããã«æ§æãããŠããŸãããã¿ãŒã³ã€ã³ã¿ã©ãããããªã¬ãŒããŠæãããªè«çççŸãéããŠã解決ãèŠæ±ãã奜å¥å¿ã®ã®ã£ãããå±éããèŠèŽè ã®ç·ãããçè§£ã®æ¢åã®ãã¬ãŒã ã¯ãŒã¯ãäžå®å šã§ãããšæããŠãã¢ã€ãã³ãã£ãã£ãäžå®å®ã«ããåæãå°å ¥ããŸããããã¯æç§æž Eugene Schwartz Stage 4 åžå Žç²Ÿå¯åºŠ ã®åãã§ãã2024 幎ãŸã§ã«ãç·æ§åŒ·åã«ããŽãªãŒã¯çŽç·çãªäž»åŒµïŒããã倧ãããªããããããé·ãç¶ãããã粟åãå¢ãããïŒã§é£œåããŠããŸãããã®æ®µéã®åžå Žæèã®è²·ãæã¯ããã¹ãŠã®çŽç·çãªçŽæãèŠãŠãããã»ãŒå ç«ããããŸããåãéãã®ã¯ãå¯äžã®ç¡æ°ã®ããã¯ãæ¬ç©ã®æ°ããã¡ã«ããºã ãæäŸããããŸãã¯èŠèŽè ãæ±ºããŠèããããšã®ãªãã¹ããŒãªãŒãã¢ãžã¢ã®ååŒã®ç©èªã¯ãæ¬ç©ã§æããã»ã©çããã§ãããæ·±ã銎æã¿ã®ããäžå®ãå©çšããããã«ãšã³ãžãã¢ãªã³ã°ãããŠããŸãã
äºæ¬¡çãªããã¯æ§é ã¯ã³ããŒã©ã€ã¿ãŒã open loop ãšåŒã¶ãã®ãæ§ç¯ããŠããŸãããã¬ãŒã¿ãŒã¯ãæåã®ã¢ã€ãã³ãã£ãã£ãéºäŒåã®ååãVSL ã®å€§ããªã¹ãã¬ããå šäœã®ååŒã®è©³çްãå·®ãæ§ããŸããçŽæãããå瀺ãéããŠåŒµåãç¶æããŸããããã¯ç¹°ãè¿ã threat interrupt ãšçµã¿åããããŠããŸããããã®ãããªã¯ãã€ãªãã©ã€ã³ã«ãªãå¯èœæ§ããããŸããããååçãªèŠèŽãã¢ã¯ãã£ãã§æéçã«å§è¿«ãããæ±ºå®ã«å€æããŸããæªè§£æ±ºã®å¥œå¥å¿ïŒéºäŒåã¯äœã§ããïŒæ€ç©ã¯äœã§ããïŒïŒãšç·è¿«æïŒãã®ããŒãžã¯æ¶ããäºå®ã§ãïŒã®çµã¿åããã¯ãä»ã®åæçæèãæå¶ããããã«èšèšãããŠãããæçå¿ãä¿ãå¯èœæ§ããããŸãã
Meta ãŸã㯠YouTube ãã¬ãŒã¹ã¡ã³ãã®ãããã®åµé æ§ãè©äŸ¡ããŠããã¡ãã£ã¢ãã€ã€ãŒã®å Žåãæ¬¡ã®èгå¯ãé¢é£ããŸããããã¯ã®äººçš®çãã¬ãŒãã³ã°ãžã®äŸåã¯ãç¹ã«æ§çã³ã³ãã³ããšå·®å¥çã¿ãŒã²ãã£ã³ã°ã«é¢ãã Meta ã®åºåããªã·ãŒäžã§ãé倧ãªãã©ãããã©ãŒã ã³ã³ãã©ã€ã¢ã³ã¹ãªã¹ã¯ãäœæããŸããçŸåšã®åœ¢åŒã® VSL ã¯ã»ãŒç¢ºå®ã«ãäž»èŠãªãã©ãããã©ãŒã äžã§ãã®å®å šçã§æ¯æãåºåãšããŠå®è¡ã§ãããã¢ãã£ãªãšã€ããããã¯ãŒã¯ãã¡ãŒã«ãªã¹ããããã³ãã€ãã£ãåºåãéããŠé åžãããå¯èœæ§ãé«ããªããŸãã
VSL ã§èгå¯ãããäºæ¬¡ããã¯ïŒ
- ãããªãã®äœã®æœåšçãªéºäŒåã¯ãç®èŠããæã«ãããã¹ã®ãµã€ãºãå¢å ãããäœéæžå°ãå éãããçèã®å¢å ãæ¹åããé«ªã®æé·ãæ¹åããŸãã
- ãå»è ãããªãã«èŠæš¡ãéèŠã§ã¯ãªããšèšã£ããªãã圌ã¯åçŽã« 10 åãã«ã®ç·æ§ã®å¥åº·ç£æ¥ãšäžèŽããŠããŸãã
- ã35,649 人以äžã®ç·æ§ã¯ããã®æ¹æ³ã§æ¢ã«äººçãå€ããŸããã
- ã圌女ã¯åœŒå¥³ã®å人ã察象ãšããé»åã¡ãŒã«ãéä¿¡ããŠããŸãããïŒå±èŸ±çãªãšã¹ã«ã¬ãŒã·ã§ã³ïŒ
- ããã®ç§å¯ã¯ãã¢ãžã¢ã®æãè£çŠãªå®¶æã«ãã£ãŠäœäžä»£ã«ãæž¡ã£ãŠä¿æãããŠããŸããã
ãã¹ãçšã®åºåèŠåºãããªãšãŒã·ã§ã³ïŒMeta / YouTubeïŒïŒ
- ãå»è ã¯ç·æ§ã®ããã®ãã®å€ä»£ã¢ãžã¢çæ³ã«ã€ããŠç¥ã£ãŠã»ãããããŸããã
- ãããã¹ãµã€ãºãå¶åŸ¡ããéºäŒåãããã³ãããèªç¶ã«åãæ¿ããæ¹æ³ã
- "35,000 人ã®ç·æ§ãããã䜿çšããŠããã倧åå»åŠå»çã¯ãããã·ã£ããããŠã³ããããšããŸãã"
- ã圌ã¯ã¢ãžã¢ç³»ã 5'2"ã誰ããä»ãŸã§ã«èŠãæå€§ã®ããã¹ãæã£ãŠããŸãããããã«çç±ããããŸãã"
- ããã®èªç¶ãªåŒã¯ãç·æ§ãæè¡ããã³ããªãã§ 3 ã€ã³ã以äžã远å ããã®ã«åœ¹ç«ã¡ãŸããã
å¿ççããªã¬ãŒãšèª¬åŸã¿ã¯ãã£ã¯ã¹
AizenPower VSL ã®èª¬åŸã¢ãŒããã¯ãã£ã¯ã©ã³ãã ã§ã¯ãªããåã¿ã¯ãã£ã¯ãåã®ãã®ã®ææ çæ®çã«åºã¥ããŠæ§ç¯ãããæå³çãªè€åã¹ã¿ããã³ã°ã·ãŒã±ã³ã¹ã«åŸããŸããã¬ã¿ãŒã¯ã¢ã€ãã³ãã£ãã£ïŒç·ãããèªå·±æŠå¿µïŒãæ»æããããšã§å§ãŸããæ¥ã®å¢å¹ ãéããŠç§»åããé°è¬ïŒå€éšæµãã¬ãŒãã³ã°ïŒã«é§åããç°åœçãªåžæãå°å ¥ãã瀟äŒç蚌æ ãéããŠæ€èšŒããæå€±åé¿ã®ç·è¿«æãéããŸããããã¯èªèå¯èœãª Problem-Agitate-SolutionïŒPASïŒ æ§é ã§ãããå®å šãªãã¬ãŒãã£ã匧ã«ããã£ãŠæ¡åŒµãããŠããŸããRussell Brunson ã epiphany bridge ã¹ããŒãªãŒãšåŒã¶ãã®ã¯ããã¬ãŒã¿ãŒã®å人çãªå€å®¹ãèŠèŽè èªèº«ã®æœåšçãªå€åã®èšŒæ ãšããŠæ©èœããŸããæŽç·Žãã¯ãåå±€ãæ¬¡ã®ããªã¬ãŒãçå°ããåã«ææ çãªããŒã¹ã©ã€ã³ããªã»ããããæ¹æ³ã«ãããŸãã
ãã® VSL ãåçŽãªç·æ§åŒ·åã®ãããããåºå¥ããã®ã¯ãäž»èŠãªã¬ããŒã§ã¯ãªããäž»èŠãªã¬ããŒãšããŠæ¥ã®æå³çãªäœ¿çšã§ãããã®ã«ããŽãªãŒã®ã»ãšãã©ã® VSL ã¯æ¥ãç°¡æœã«äœ¿çšããŠãããç±æã«é§åããŸããAizenPower ã¯ãã©ã³ã¿ã€ã ã®é¡èãªå²åãè²»ãããŸãããã¬ãŒã¿ãŒã®æ¥ã®çµéšã®å åŽãèªæ®ºè¿ãã®é瀺ãå«ããå®å šã« 3 åã® 1 ã®ãã¬ãŒãã£ããããã¯èšç®ãããŠããŸããæ¥ãäœãã§ããŠãããé®®ããã«èŠããã»ã©ãèŠèŽè ãç¶ãåºå£ãå¿ èŠãšããŸããã¿ã¯ãã£ãã¯ã¯æ²»ççãªã¹ããŒãªãŒããªã³ã°æ§é ããåããŸããæ²»çãæ¥ãåŠçããã³è§£æŸããããã«ãã¬ãŒãã£ãã䜿çšããŠããéãVSL ã¯ããã 匷åããŠå©çãããããããã«äœ¿çšããŠããŸãã
ãã¿ãŒã³ ã€ã³ã¿ã©ããïŒCialdiniã2006ïŒïŒ ãªãŒããã³ã°å ã®äººçš®çã¹ãã¬ãªã¿ã€ãã®å転ã¯ãäºæããããã¬ãŒãã£ãã«éåããããšã§èªç¥ãšã³ã²ãŒãžã¡ã³ãã匷å¶ããŸããèŠèŽè ã¯ã圌ãã®è³ãççŸã解決ããããšããŠãããããèŠãããšãã§ããŸãããç¹å®ã®ç¬éïŒVSL ã®æåã® 10 ç§ã
False Enemy / é°è¬ãã¬ãŒãã³ã°ïŒCialdini ã® ã°ã«ãŒãå ãã€ããã¯ã¹ïŒïŒ Big Pharma ã¯ãAizenPower ã®ç§å¯ã®æå¶è ãšããŠäœçœ®ä»ããããŠãããè³Œå ¥ããã©ã³ã¶ã¯ã·ã§ã³ã§ã¯ãªãåä¹±ã®è¡çºã®ããã«æããããŸããç¹å®ã®ç¬éïŒã10 åãã«ã®ç·æ§ã®å¥åº·ç£æ¥ã¯ 1 幎éã« 54 åãã«ãäœæããŠãããã·ã³ãã«ã§èªç¶ãªæ¹æ³ããã¹ãŠãå±éºã«ãããããšãæãã§ããŸããã"
æå€±åé¿ïŒKahnemanïŒTverskyã1979 Prospect TheoryïŒïŒ ç·æ¥æ§ãã¬ãŒãã³ã°ãå»åŠçåŒè·å£«ã1 é±éã®äŸçµŠãŠã£ã³ããŠã次ã®ãããã® 6 ã 9 ãæã®åŸ æ©ãè³Œå ¥ãã²ã€ã³ïŒãã倧ãããªãïŒããæå€±é²æ¢ã¢ã¯ã·ã§ã³ïŒç¶ç¶çãªæ¥ãåé¿ïŒã«å€æããŸããç¹å®ã®ç¬éïŒããã®ãããã¯ã»ãŒç¢ºå®ã« 1 é±éã§å®è¡ãããŸããã
æ¥å¢å¹ âã¢ã€ãã³ãã£ãã£æå©ïŒFestinger ã®èªç¥çäžèª¿åïŒïŒ ãã¬ãŒã¿ãŒã®å±èŸ±ãã¬ãŒãã£ãã¯ãèŠèŽè ã®çŸåšã®èªå·±ãšæãŸããèªå·±ãšã®éã«æå€§ã®å¿ççè·é¢ãäœæãããã®åŸã補åãæ©ããããããã«äœçœ®ä»ããããŸããèªæ®ºè¿ãã®é瀺ã¯ãææ ã®ããŒã¯ã§ããæå€§ã®äžèª¿åã®ç¬éã§ããããããããœãªã¥ãŒã·ã§ã³ãåè¡¡ãããããã«æããããŸããç¹å®ã®ç¬éïŒãæ¥ãšèŠãã¿ã¯ç§ã«èªæ®ºãèæ ®ããããå°ããŸãããã
æš©åšåçš/ ãããŒå¹æïŒThorndikeã1920ïŒïŒ ããŒããŒãããªãã¯ã¹ãã©ãŒãããžã£ãŒãã«ã»ãªãã»ãŠãããžãŒã¯æ€èšŒå¯èœãªåŒçšãªãã§åŒãåºãããŠããŸããããããã®ååšã¯èªåä¿¡é Œè»¢éãããªã¬ãŒããŸããç¹å®ã®ç¬éïŒããã®ç§å¯ã¯ããŒããŒãããªãã¯ã¹ãã©ãŒããã¢ã¡ãªã«æ§ç åŠå§å¡äŒããã®å°éå®¶ããã®ç ç©¶ã«ãã£ãŠæ€èšŒãããŠããŸããã
瀟äŒç蚌æ ã¹ã¿ããã³ã°ïŒCialdiniã2006ïŒïŒ å°ççç¹ç°æ§ïŒå·ã幎霢ïŒãæã€ 5 ã€ã®ååã®èšŒæ ãš 35,649 ã®äž»åŒµããããŠãŒã¶ãŒ ããŒã¹ã¯ãã³ã³ã»ã³ãµã¹ã®èªèãäœæããŸãã女æ§ã®èšŒæ ïŒMarissa C.ïŒã®å«æã¯æŽç·Žãããã¿ããã§ããããã¯è£œåã®æçµçãªæå³ãããåçè ã®èгç¹ããäž»åŒµãæ€èšŒããŸããç¹å®ã®ç¬éïŒMarissa ã®èšŒæ ã«ã€ããŠåœŒå¥³ã®å€«ã
Endowment Effect ãš Risk ReversalïŒThalerã1980ïŒïŒ 60 æ¥éã®è¿éä¿èšŒã¯ãæšæºçãªæ¶è²»è ä¿è·ã§ã¯ãªãããã¬ãŒã¿ãŒããã¹ãŠã®ãªã¹ã¯ãååŸããšããŠãã¬ãŒãã³ã°ãããŠããŸããããã¯å¿ççã«ãè³Œå ¥åã«è³Œå ¥è ãžã®çµæã®èªç¥æææš©ã転éããéè³Œå ¥ãæ¢ã«åŸãäœããæ²¡åã®ããã«æããããŸããç¹å®ã®ç¬éïŒãããã§ãã¹ãŠã®ãªã¹ã¯ãååŸããŠããŸããã€ãŸãã倱ããã®ã¯äœããããŸãããã
ãããã®ã¿ã¯ãã£ã¯ã¹ã 50+ VSL ã§ã©ã®ããã«æ¯èŒãããŠããããèŠããã§ããïŒ ããã¯ãŸãã« Intel Services ã衚瀺ãããããã«æ§ç¯ãããŠãããã®ã§ãã
ç§åŠçããã³æš©åšã·ã°ãã«
AizenPower VSL ã¯ã4 ã€ã®ãœãŒã¹ããæš©åšãæ§æããŸãã䞻匵ãããå»åŠçèªå®æ å ±ãæã€ãã¬ãŒã¿ãŒãååä»ãã®åŠè¡æ©é¢ãç¹å®ã®ç ç©¶ãããã³ç°åœçãªäººé¡åŠçäŒçµ±ãåãœãŒã¹åãæ£çŽã«è©äŸ¡ããããšã¯ãæ å ±ã«åºã¥ããæ±ºå®ãäžãèªè ã«ãšã£ãŠäžå¯æ¬ ã§ãã
ãã¬ãŒã¿ãŒãã¢ãŒãã«ã P. ãžã§ã€ã¹ãã¯ãç·æ§ã®æ§çå¥åº·ãæ²»çãã 20 幎ã®èšåºçµéšãæã€å»åŠç ç©¶å°éå®¶ãšããŠèª¬æãããŠããŸãã確èªå¯èœãªæ å ±ãæ©é¢æå±ãåºçèšé²ãè·æ¥çã©ã€ã»ã³ã¹ã¯ããã®ã¢ã€ãã³ãã£ãã£ã確èªããããã«æäŸãããŠããŸããããã®ååã¯ãå ¬éãããŠããæ€çŽ¢ã«åºã¥ããå»åŠçã©ã€ã»ã³ã¹ ããŒã¿ããŒã¹ãŸãã¯ç·æ§ã®æ§çå¥åº·ã«é¢ããå ¬è¡šãããç ç©¶æç®ã«è¡šç€ºãããŸãããããã¯ãæåãèæ§ã§ããããšã決å®çã«èšŒæããŸãããã䞻匵ãããæš©åšã¯å®å šã«æ€èšŒã§ããªãããšãæå³ããŸããïŒåã«ãDr. Xãã§ã¯ãªãïŒå®å šãªé©åãªååã䜿çšããããšã¯ãæ€èšŒææ®µãæäŸããã«è²¬ä»»ã®èŠããã®å€èгãäœæããŸããèŠå¶ãããå¥åº·ãããã«ããã VSL ãã¬ãŒãã£ãã§äžè¬çãªãã¯ããã¯ã
æ©é¢ã®åŒçšïŒããŒããŒãããªãã¯ã¹ãã©ãŒããã¢ã¡ãªã«æ§ç åŠå§å¡äŒïŒã¯ããã®çŽç²ãªåœ¢åŒã§ åçšæš©é ã§ãããããã®æ©é¢ã¯ãVSL ã®äž»åŒµããµããŒãããç ç©¶ã宿œãŸãã¯æ¯æããŠãããšããŠãæž¡ããŠåç §ãããŠããŸãããç¹å®ã®ç ç©¶ã®ã¿ã€ãã«ãèè ãåºçæ¥ããŸãã¯ãžã£ãŒãã«åã¯æäŸãããŠããŸãããã¢ã¡ãªã«æ§ç åŠå§å¡äŒã¯å®åšã®çµç¹ã§ãããVSL ãæå³ããæèŠã§ç ç©¶ã宿œããŠããŸãããããŒããŒã倧åŠãšãªãã¯ã¹ãã©ãŒã倧åŠã¯ãç¹å®ã®æ€çŽ¢å¯èœãªèšŒæ ã®ãœãŒã¹ã§ã¯ãªãããã©ã³ãåãšããŠåŒãåºãããŠããŸãããã®ç ç©¶ãç¹å®ããããšããèªè ã¯ãäœãèŠã€ãããŸãããåŒçšã¯èšŒæ çã§ã¯ãªããã¬ããªãã¯çã§ããããã§ãã
æé®®äººååŒçšãJournal of Urology ã§ 900mg 3 å 1 æ¥ 3 åã§ 18 é±éã«ããã 45 ã® ED æ£è ã調ã¹ãç ç©¶ã¯ãå®åšããå ¬è¡šãããç ç©¶ã«å¯Ÿå¿ããããã«èŠããŸããde Andrade et al. ã«ããäœæ¥ïŒ2007ïŒããã³æé®®ã®ç ç©¶ã°ã«ãŒãããã®åæ§ã®ç ç©¶ã¯ãåèµ·äžå šã®ããã® Panax ginseng ã調ã¹ãå°¿åŠæç®ã«è¡šç€ºãããŸããåèµ·å質枬å®ã®çµ±èšçã«ææãªæ¹åã瀺ã調æ»çµæãããã¯ãVSL ã®åŒçšãããŠããç§åŠãå®åšããå ¬è¡šãããäœæ¥ã«ãã¬ãŒã¹ã§ããç¬éã§ããã¢ã«ãã¡ãªãé žç ç©¶ã¯ãMedicine Journalãã«åž°å±ããŠãããäžãããã説æããæ€èšŒããããšã¯ã§ããŸãããED æ²»çã§äž»åŒµããã 90% ã®æåçã¯ãæç®ã§ç¥ãããŠãã ALA ç ç©¶ã§å ±åããã广ãµã€ãºãšäžèŽããŠããŸããã倧éªã® SRY éºäŒåç ç©¶ãåŒçšããŠããã¹ãµã€ãºã®éºäŒç決å®è«ã確ç«ããããšã¯ãæ¬ç©ã®éºäŒåçç©åŠãåç §ããŸããSRY éºäŒåã¯ç¢ºãã«æ§ç決å®ã«é¢äžããŠããŸããããã®éçºæ©èœãç¡èŠããŠããæäººè£å ãžã®å€æ¿ã«ã¯ç§åŠçæ ¹æ ããããŸããã
ãªãã¡ãŒãäŸ¡æ Œèšå®ãããã³ãªã¹ã¯å転
AizenPower ã®äŸ¡æ Œèšå®ã¢ãŒããã¯ãã£ã¯ãæç§æž äŸ¡æ Œã¢ã³ã«ãŒã·ãŒã±ã³ã¹ ã§ãããã¬ãŒã¿ãŒã¯ãåäžã®ããã«ã®ãçã®ãå€ãšã㊠290 ãã«ã確ç«ãã圌ããè«æ±ããäºå®ã ã£ãããšããå€ã§ãããšäž»åŒµããŠããã190 ãã«ãš 90 ãã«ãéããŠåäžè³Œå ¥ã§ 69 ãã«ã®ããã«ãããã«çå°ããåã«æ©ãäžããŸãã6 ããã«ããã±ãŒãžã§ 49 ãã«ã®ããã«ãããããã®äžéã¢ã³ã«ãŒã¯ãå®èšŒãããŠããªããµããªã¡ã³ãã®å®éã®äŸ¡æ Œã§ã¯ãªããåçãªå²åŒã®ããã« 69 ãã«ãæããããããã«èšèšãããŠããŸããæ¯èŒã¯ 290 ãã«ããæ€èšŒå¯èœãªã«ããŽãªãŒã®å¹³åã«å¯ŸããŠãã³ãããŒã¯ãããŠããŸããããããã®å®éã®äŸ¡æ Œãå®å€ã®ããã«æããããããã ãã«çºæãããå éšã¢ã³ã«ãŒã§ããåæ³çãªäŸ¡æ Œã¢ã³ã«ãŒãªã³ã°ã¯ãæ€èšŒå¯èœãªã«ããŽãªãŒã®å¹³åãåç §ããŸãïŒäŸïŒãæè¡è²»çšã¯ 3,000 ïœ 8,000 ãã«ãïŒããã® VSL ã®ã¢ã³ã«ãŒã¯ã¬ããªãã¯çã§ãã
6 ããã«ã®ã¢ããã»ã«ã¯ãåãªãå²åŒã§ã¯ãªããå»åŠçå¿ èŠæ§ãšããŠæ§æãããŠããŸããVSL ã¯ãå¹æãæ°žç¶çã«ãªãã«ã¯ 2 ã 4 ãæã®ç¶ç¶äœ¿çšãå¿ èŠã§ããããããã¹æé·éºäŒåãé尿޻åç¶æ ã§ãã㯠and ã·ãŒã«ãããã«ã¯ç¶ç¶çãªãµããªã¡ã³ãåãå¿ èŠã§ãããšäž»åŒµããŸããããã¯ããªã¥ãŒã è³Œå ¥è°è«ã§ããå»åŠçã¢ããã€ã¹ãšããŠçè£ ããã平忳šæå€ãå¢å ãããªããæãæ»ããªã¯ãšã¹ãã®å¯èœæ§ãåæžããããã«èšèšãããŠããŸãïŒã»ãšãã©ã® 6 ããã«ãè³Œå ¥ããè²·ãæã¯ããããã³ã«ã«å¿ççã«ã³ãããããŠããããã§ãïŒãéæç¡æã®å«æã¯ãæ¬ç©ã®è²¡æ¿å€è¿œå ã§ãããäžæ¬¡çã«ã¯æå€±åé¿ããªã¬ãŒãšããŠæ©èœãããã¬ãŒãã³ã° ãã³ãã«ãè²·ãç©ã®å²åŒãè¶ ãã貯èãçæããŠã
60 æ¥éã®è¿éä¿èšŒã¯ãåé¢ããããã«ãæå³ã®ããæ¶è²»è ä¿è·ã§ãã60 æ¥éã¯ãã»ãšãã©ã®ãµããªã¡ã³ã广ãè©äŸ¡ããã®ã«ååã§ãããå®å šææ»ããªã·ãŒã¯æå³ã®ããééçãªã¹ã¯è»¢éã§ããããããVSL ã§ã®ä¿èšŒã®ã¬ããªãã¯çæ©èœã¯ãæ¬ç©ã®ææžææ®µãæäŸããã®ã§ã¯ãªããè³Œå ¥è ã®å¿ã®æåŸã®ç°è°ãè§£æ£ãããããšã§ãããã¬ãŒã¿ãŒã®ã¹ããŒãã¡ã³ãã§ã¯ã圌ã¯ãéåžžã«é©ããããŸããããªããèŠæ ãæã£ãŠãããªããã35,500 人åã®å šãŠãŒã¶ãŒãå€§èŠæš¡ãªçµæãçµéšããããšãèãããšïŒä¿èšŒãè¡äœ¿ããããšãç°åžžã§ããããæ¥ããããããšããæç€ºããŠããŸããããã®äœ¿çšã埮åŠã«èœèãããŸãã
ããã¯èª°ã®ããã®ãã®ïŒãããŠèª°ã§ã¯ãªãã®ãïŒ
AizenPower ã®ãããã¯ãããªããªç²Ÿå¯åºŠã§ç¹å®ã®å¿ççãããã¡ã€ã«ã®ããã«èª¿æŽãããŠããŸããçæ³çãªè²·ãæã¯ããããã 35 ã 65 æ³ã®éã®ç·æ§ã§ãæ§çããã©ãŒãã³ã¹ãŸãã¯ããã¹ãµã€ãºã«ã€ããŠæ¬ç©ã®èŠçãçµéšããŸãããåãªã奜ã¿ã§ã¯ãªãã圌ã¯ãããããå°ãªããšã 1 ã€ã®ä»ã®ãœãªã¥ãŒã·ã§ã³ïŒãã³ãããµããªã¡ã³ããæŒç¿ïŒãæºè¶³ã®ãªã人ã§è©Šã¿ãããšããããŸãã圌ã¯ãããããæ§çäžååãã«ãå°ãªããšãããã€ãã®é¢ä¿å€±æãçµéšããå¯èœæ§ããããŸãããã®ããã«ã圌ã¯å€§ããªæ¥ãéã³ãŸãã圌ã¯ã€ã³ã¿ãŒãããèªã¿åãèœåããããé·ç·šãããªã»ãŒã«ã¹ã¬ã¿ãŒãèŠãã®ã«ååã§ãããåŒçšãããç ç©¶ãå³åº§ã«æ€èšŒããã»ã©ç ç©¶å¿åã§ã¯ãããŸãããéèŠãªããšã«ãåœŒã¯ææ çã«äœããã€ã³ãã«ããããã¬ãŒã¿ãŒã®æ¥ã®ã·ããªãªãšã®èå¥ãžã® VSL ã®ç¹°ãè¿ãããæåŸ ç¶ã¯ãåé¢ãããã§ãåççãªè©äŸ¡ã®ç¬éã§ã¯ãªããè匱æ§ã®ç¬éã§äººã ããã£ããããããã«èšèšãããŠããŸãããã®ãããã¡ã€ã«ã¯ã¹ããŒããŒã§ã¯ãªããæ¬ç©ã®çª®è¿«ãçµéšããæ¬ç©ã®çª®è¿«ãçµéšãããã®æé¬±ã説æããç·æ§ã®æ¬ç©ã®äººå£ã説æããŸããããã¯ãŸãã«ããããã广çã«ããåæã«å«ççã«åé¡ããããŸãã
è¡ç®¡æåã®çãããåèµ·äžå šãå®éã«çµéšããŠããç·æ§ã«ãšã£ãŠãAizenPower åŒã®å人çãªæåãæé®®äººåãäºéãã¬ã¹ãã©ãããŒã«ãè¡ç®¡ã®å¥åº·ãšç²Ÿåã¬ãã«ããµããŒãããããã®åŠ¥åœã§æ§ãããªèšŒæ ããŒã¹ããããŸãã補åã®åŒãæ£ç¢ºã«ã©ãã«ãããæäžéãäžååãªå Žåããã®ã«ããŽãªãŒã®è²·ãæã¯ãåºç€çãªæåç ç©¶ã§èŠããã人ãšäžèŽããåèµ·å質ã®éççæ¹åãçµéšããå¯èœæ§ããããŸãã圌ã¯éºäŒå掻æ§åãæ°žç¶çãªè§£ååŠçæé·ããŸã㯠VSL ã® 3 ã 7 ã€ã³ãã®è«æ±ã®äœãã«é¡äŒŒããäœããæåŸ ããã¹ãã§ã¯ãããŸããã
誰ãçµéãã¹ããïŒæ°žç¶çãªããã¹é·å¢å ã®ç¹å®ã®çŽæãäž»èŠãªåæ©ã§ããä»»æã®ç·æ§ããã®çµæã¯ããã®ããŸãã¯ãã®ä»ã®ãµããªã¡ã³ãã§ãä¿¡é Œã§ããç§åŠçã¡ã«ããºã ããããŸãããæ§çæ©èœã«åœ±é¿ãäžãã蚺æå»åŠçç¶æ ãæã€ç·æ§ãç³å°¿ç é¢é£ EDãåç«è ºåé€åŸåèµ·äžå šãäœãŽãããŽãã€ã³ãã¯ããµããªã¡ã³ã VSL ã§ã¯ãªããæ³å°¿åšç§å»ãŸãã¯å åæ³åŠè ã§åãã¹ãã§ããç¹ã«æ¥ããŒã¹ã®ããŒã±ãã£ã³ã°ã«è匱ã§ãå°é£ãªææ ã®ææã«ããã¹ãç·æ§ïŒVSL ã¯ãŸãã«ãã®ç¶æ ã§äººã ããã£ããããæèãçºçããåã«è³Œå ¥æ±ºå®ãå éãããããã«ãšã³ãžãã¢ãªã³ã°ãããŠããŸãã
決å®ããåã«è€æ°ã®ç·æ§ã®å¥åº·ãµããªã¡ã³ãã調æ»ããŠããŸããïŒ Intel Services ã¯å®å šãªæ¯èгãã«ããŒããŸããä»ã®è£œåã®å èš³ã«ã€ããŠèªã¿ç¶ããŠãã ããã
ãããã質å
Q: AizenPower ã¯æ¬åœã«ããã¹æ¡å€§ã«æ©èœããŸããïŒ
A: ç§åŠç蚌æ ã¯ãé£äºãµããªã¡ã³ããæœåšçãªéºäŒåãæŽ»æ§åããããšã«ãã£ãŠããã¹ã®é·ããæ°žç¶çã«å¢å ãããããšãã§ãããšãã䞻匵ããµããŒãããŠããŸãããAizenPower ã®ããã€ãã®å人çãªæåãæé®®äººåãäºéãã¬ã¹ãã©ãããŒã«ïŒåèµ·æ©èœãšè¡ç®¡ã®å¥åº·ã®æ§ãããªæ¹åã«é¢ãã蚌æ ããããŸããæ°žç¶çãªè§£ååŠçæé·ã¯ãµããªã¡ã³ãè£å
ã«ãã£ãŠãµããŒããããŠããŸããã
Q: AizenPower ã¯è©æ¬ºã§ããïŒ
A: 補åã¯ãéºäŒå掻æ§åãéãã 3 ã 7 ã€ã³ã以äžã®æ°žç¶çãªããã¹æé·ãå«ãç°åžžãªäž»åŒµãè¡ããä¿¡é Œã§ããç§åŠçæ ¹æ ããããŸããããã¬ãŒã¿ãŒã®èªå®æ
å ±ã¯ç¬ç«ããŠæ€èšŒããããšã¯ã§ãããã»ãšãã©ã®æ©é¢åŒçšïŒããŒããŒãããªãã¯ã¹ãã©ãŒãïŒã¯æ¬ç©ã®ç ç©¶ã«åºãããã®ã§ã¯ãªããã¬ããªãã¯çã«äœ¿çšãããŠããŸããå人çãªè²·ãæãå«ãŸããæåããå©çãçµéšãããã©ããã¯ã圌ãã®ç¹å®ã®å¥åº·ããŒã¹ã©ã€ã³ãšå®éã®åŒã«äŸåããŸãã
Q: AizenPower ã®æåã¯äœã§ããïŒ
A: VSL ã«ãããšãåŒã«ã¯ Asian Gold ThreadïŒãã«ããªã³ïŒãã¯ã¬ãŒãããŒãã«ãã³ããœã«é
žãã¢ã«ãã¡ãªãé
žããã³ãã£ïŒé°å¹²ãæ¹è¶ïŒãã¬ã¹ãã©ãããŒã«ãMilk Thistleãã±ã€ãšã³ããããŒãæé®®äººåæ ¹ãäºéïŒ11mgïŒãã¯ãã ãå«ãŸããŠããŸããããã€ãã¯ãããã¯è¡ç®¡ããã³ ãã«ã¢ã³ã®å¥åº·ã®ããã®åæ³çãªç¬ç«ããç ç©¶æ¯æŽãæã£ãŠããŸããããã¹æ¡å€§ã«ã€ããŠç¹ã«èšŒæ ã¯ãããŸããã
Q: AizenPower ã®å¯äœçšã¯ãããŸããïŒ
A: VSL ã¯ãåŒããæå®³ãªå¹æããªãããä¿æããŠãããšäž»åŒµããæåéãã¢ã¬ã«ã®ãŒããªã¬ãŒã¬ãã«ã®äžã§ããå®éã«ã¯ãããã€ãã®æåã¯æ¢ç¥ã®çžäºäœçšãªã¹ã¯ãéã³ãŸãã人åã¯è¡æ¶²ã·ã³ããŒãšåºæ¿å€ãšçžäºäœçšã§ããŸãããã«ããªã³ã¯è¡ç³ã«åœ±é¿ãäžããç³å°¿ç
æ£è
ã«ãã£ãŠæ
éã«äœ¿çšãããã¹ãã§ããã±ã€ãšã³ã¯ãããé«ãçšéã§èè
žçµç¹ãåºæ¿ããå¯èœæ§ããããŸããåŠæ¹è¬ã§ããŠãã人ã¯ãæ°ãããµããªã¡ã³ããæåããåã«å»åŠå»åž«ã«çžè«ããã¹ãã§ãã
Q: AizenPower ã¯ä»ã®ãµããªã¡ã³ãã§å®å
šã«äœ¿çšã§ããŸããïŒ
A: VSL ã¯ãããããããã¹é¢é£ã®åé¡ã®ã¿ã察象ãšããããããä»ã®ãµããªã¡ã³ããšå¹²æžããªããšäž»åŒµããŠããŸããããã¯ãè¬çåŠçã«æå³ã®ãã䞻匵ã§ã¯ãªãããµããªã¡ã³ãã¯æå³ãããç®çã§ã¯ãªãããããã®çååŠçæåã«åºã¥ããŠçžäºäœçšããŸããå
·äœçã«ã¯ããã«ããªã³ãšã¬ã¹ãã©ãããŒã«ã¯ãä»ã®ååç©ãã©ã®ããã«ä»£è¬ããããã«åœ±é¿ãäžããç¹å®ã®çްèè²çŽ P450 é
µçŽ ãé»å®³ããŸãã
Q: AizenPower ããçµæãèŠãã®ã«ã©ã®ãããããããŸããïŒ
A: VSL ã¯ãå
éšçµæããå³åº§ãã§ãå€éšçµæããæéããªãããšäž»åŒµããŠããŸãããå¹æãæ°žç¶çã«ãªãã«ã¯ 2 ã 4 ãæãå¿
èŠã§ãããšè¿°ã¹ãŠããŸãããããã®ã¿ã€ã ã©ã€ã³ã¯ççŸããŠãããäž»ã«èšåºèšŒæ ãåæ ããã®ã§ã¯ãªããè€æ°ã®ããã«ã®è³Œå
¥ãæ£åœåããŸãã
Q: AizenPower ã®è¿éä¿èšŒã¯äœã§ããïŒ
A: VSL ã¯ãé»åã¡ãŒã«èŠæ±ãéããŠæãæ»ãã®ããã«çç±ã®ããã« 60 æ¥éã100% æãæ»ãä¿èšŒãæäŸããŠããŸãã60 æ¥éã®ãŠã£ã³ããŠã¯ãäŒç€Ÿããããç§°ããã¹ãå Žåã¯æ¬ç©ã®æ¶è²»è
ä¿è·ã§ããæœåšçãªè²·ãæã¯ã賌å
¥ããåã«ç¬ç«ããæ¶è²»è
ã¬ãã¥ãŒãã©ãããã©ãŒã ãéããŠäŒç€Ÿã®æãæ»ããã©ãã¯ã¬ã³ãŒããç ç©¶ããã¹ãã§ãã
Q: ã©ãã§ AizenPower ã賌å
¥ã§ããŸããïŒ Amazon ã§å©çšå¯èœã§ããïŒ
A: VSL ã«ãããšãAizenPower ã¯ç¬èªã®ãŠã§ããµã€ããéããŠã®ã¿è²©å£²ãããAmazonãeBayãEtsyããŸãã¯ãµãŒãããŒãã£ã®ãã©ãããã©ãŒã ã§ã¯å©çšã§ããŸãããVSL ã¯ãä»ã®å Žæã§èŠã€ãã£ãããŒãžã§ã³ã¯åœç©ã§ãããã®ç¬å è«æ±ã¯ãå®åšãã顧客çµéšãè©äŸ¡ãããµãŒãããŒãã£ã®å£²ãæã¬ãã¥ãŒããŒã¿ããªãããšãæå³ããŸãã
æçµãã€ã¯
AizenPower VSL ã¯ã説åŸçãªã©ã€ãã£ã³ã°ã®äžéšãšããŠãæè¡çã«éæãããŠããŸããããã¯æ¬ç©ã®ãã¬ãŒãã£ãå¢ããåããããŒããŒ'sãžã£ãŒããŒæ§é ãå±éããæå³çãªã·ãŒã±ã³ã¹ã§å¿ççããªã¬ãŒãã¹ã¿ãã¯ããè³Œå ¥æ±ºå®ããæåŸã®æ©æŠç¹ãåé€ããç·æ¥æ§ãšãªã¹ã¯å転æ©å¶ãåããä¿¡é Œã§ããååãªäºå®æç« ãåããåœã®æµãæ§æããŸããã¡ãã£ã¢ãã€ã€ãŒãŸãã¯ã³ããŒã©ã€ã¿ãŒãé·ç·š VSL æ§é ãå匷ããããšã¯ããã³ããšæ¥å¢å¹ ãäž»èŠãªåæ©ãšããŠäœ¿çšããããšããåŠã¶ããšãã§ããŸãããã®äœ¿çšã®å«ççãªåœ±é¿ãæ©ãŸãããšããŠããç°åœçãªèµ·æºã®ç©èªã¯ãç¹ã«ã飜åããæççãªåžå Žã§æ°ããã¡ã«ããºã ã®äž»åŒµãã©ã®ããã«å£²ãããšããæ¬ç©ã®ããŒã±ãã£ã³ã°åé¡ã®åµé çãªãœãªã¥ãŒã·ã§ã³ã§ããèšåºçãªäººã§ã¯ãªãã人é¡åŠçãªãã¬ãŒãã£ãããæš©åšãåããããšã¯ãèŠå¶èšèªãåé¿ããªãã説åŸçãªåãä¿æããçãã§ãã
補åãã®ãã®ã¯å¥ã®åé¡ã§ããäžå€®ã®äž»åŒµãAizenPower ã SRY éºäŒåãæŽ»æ§åããŠæ°ããããã¹çµç¹ãçæããæ°žç¶çã«ããã¹ã®é·ãã 3 ã 7 ã€ã³ã以äžå¢å ããããšããããšã¯ãå ¬è¡šãããªã忥è ã«ããã¬ãã¥ãŒç§åŠã«ãã£ãŠãµããŒããããŠããŸãããSRY éºäŒåã¯åºçåçºéäžã«åäœããŸããæäººè£å ã¯ãã®çºéæ©èœãå床掻æ§åããããšã¯ã§ããŸãããåŒã®ããã€ãã®æåã¯ãè¡ç®¡ã®å¥åº·ã粟åã¬ãã«ãããã³åèµ·æ©èœããµããŒãããããã®åæ³çã§æ§ãããªèšŒæ ãæã£ãŠããŸãããã®ããã軜床ããäžç床ã®è¡ç®¡ ED ãæã€ç·æ§ã«æ©æµãäžããããšãã§ããŸããããããç§åŠããµããŒãããŠãã人㚠VSL ãçŽæãããã®éã®ã®ã£ããã¯ãä¿å®çå¯Ÿç©æ¥µçãªè§£éã®åé¡ã§ã¯ãããŸãããã«ããŽãªãŒå¥ã§ãããã®ãããã®æã匱ãéšåã¯ãŸãããã®è²¡å£ã§ãã
ãã® VSL ãåžå Žã«ã€ããŠæãããŠããããšã¯éèŠã§ããããã¹æ¡å€§è£œåã®æ°žç¶æ§ãèŠå¶æªçœ®ãã¡ãã£ã¢æé²ãæ¶è²»è 倱æã®æ°å幎ã«ããã£ãŠåæ ããŠããã®ã¯ã補åãã¢ãã¬ã¹æå®ããããŒãºã¯æ¬ç©ã§ãããäž»ã«å»åŠå»åŠã«ãã£ãŠã»ãŒæºããããŠããªããšããäœãã§ããããã¹å€åæ§é害ãŸãã¯æ¥é§åæ§çé¿ããçµéšããŠããç·æ§ã«ã¯ãæ²»çãžã®å°æ°ã®åæ³çãªçµè·¯ãããããããã®æžå¿µã«é¢ããèšåºäŒè©±ã¯äŸç¶ãšããŠã¹ãã£ã°ãã眮ãããŠããŸãããã®ã®ã£ããã«ã補åã®ãã㪠AizenPower ã¯å€§ããªæŽç·Žãé²ããŠããŸããåŒã¯ãµããªã¡ã³ã以äžã®ããšã«ã€ããŠã§ãããããå€ãã®ããšã«ã€ããŠã§ãããã¬ãŒãã£ãïŒããªããæåŸã«èŠã€ãããã®ãèŠã€ããŠãããšããæèŠãç§å¯ã誰ãããªããèŠã€ããããªãããšãç§å¯ã«ããŠããŸãããã®æ°æã¡ã¯ãå€§èŠæš¡ã«è£œé ããã販売ãããŠããå®éã®è£œåã§ãã
è³Œå ¥æ±ºå®ãäžããŠããèªè ã®å ŽåïŒãã®åŒã«å«ãŸããããããã®æåã¯ãã»ãšãã©ã®å¥åº·ãªæäººã®èª¬æãããæäžéã§ã¯å±éºã§ã¯ãªããããã€ãã¯äžè¬çãªãŠã§ã«ãã¹ã®å©ç¹ãæäŸããå¯èœæ§ããããŸããéºäŒå掻æ§åãšæ°žç¶çãªè§£ååŠçæé·ã®ç¹å®ã®çŽæã¯ãç§åŠã«ãã£ãŠãµããŒããããŠããããå»åŠçäºå®ã§ã¯ãªããããŒã±ãã£ã³ã°è«æ±ãšããŠæ±ãããã¹ãã§ããæ§çå¥åº·ã®æžå¿µãããªãã®ç掻å質ãŸãã¯é¢ä¿ã«åœ±é¿ãäžããå Žåãæ³å°¿åšç§å»ãŸãã¯æ§çå¥åº·å°éå»ãšã®äŒè©±ã¯ããããªã»ãŒã«ã¹ã¬ã¿ãŒãéããŠè³Œå ¥ããããµããªã¡ã³ããããã¯ããã«çç£çã«ãªããŸãã
ãã®å 蚳㯠Intel Services ãVSL ããã³åºåã³ããŒåæã®ç¶ç¶çãªã©ã€ãã©ãªã®äžéšã§ããåæ§ã®è£œåã調æ»ããŠããå Žåã¯ãèªã¿ç¶ããŠãã ããã
å 責äºé ïŒãã®èšäºã¯ç ç©¶ããã³æè²ç®çã®ããã ãã§ããå»åŠçãæ³çããŸãã¯è²¡æ¿çãªã¢ããã€ã¹ã§ã¯ãªãã補åãŸãã¯ãã®è£œé æ¥è ãšææºããŠããŸãããå¥åº·ãŸãã¯è²¡æ¿çãªæ±ºå®ãããåã«ãåžžã«é©æ Œãªå°éå®¶ã«çžè«ããŠãã ããã
Comments(0)
No comments yet. Members, start the conversation below.
Related reads
- DISreviews
GumAktivã¬ãã¥ãŒãšåºååæïŒãªãµãŒããã¡ãŒã¹ãã®èå¯
GumAktivãããªã»ãŒã«ã¹ã¬ã¿ãŒïŒVSLïŒã®åé æ°ç§éã¯ãã¹ã¯ããŒã«äžã®ãã¥ãŒã¢ãŒãéã¥ãã«ããããã«èšèšããã質åãå±éããŸãïŒããããã®éããã¯ããªã¢ã¯ãæ¯ç§ã€ã³ãã©ã³ããããéããããè¿ éã«ããªãã®æ¯ã修埩ã§ããã§ããããïŒããšãããã¬ãŒãº...
Read - DISreviews
BurnSlim VSL ãšåºååæ
BurnSlim ã®ãããªã»ãŒã«ã¹ã¬ã¿ãŒã®åé æ°ç§ã®ã©ããã§ãç¹å®ã®ä¿®èŸçãªè³ãã眮ãããŠããŸããèŠèŽè ã¯ãã±ãªãŒã»ã¯ã©ãŒã¯ãœã³ãæ¯æãŒã©ãã³ã®ç«æ¹äœã 1 ã€é£ã¹ãããšã§ 68 æ¥éã§ 60 ãã³ãäœéãæžããããšèšãããŠããŸãâŠ
Read - DISreviews
BurnFlow ã¬ãã¥ãŒãš VSL åæ
BurnFlow ãããªã»ãŒã«ã¹ã¬ã¿ãŒã®ãªãŒããã³ã° 30 ç§ã¯ã補åããå§ãŸããŸãããã»ã¬ããªãã£ã®åçœããå§ãŸããŸãããã¬ãŒã³ã¿ãŒã¯ã女åªã¬ãã«ã»ãŠã£ã«ãœã³ãšã®ãã¬ã¹ã€ã³ã¿ãã¥ãŒãšããŠãã¬ãŒãã³ã°ããããã®ããé³èªããŸãããã®äžã§ãåœŒå¥³ã¯æ¯æãŒã©ãã³ãã¥ãŒããé£ã¹ãããšã§ 2 ã¶æã§ 77 ãã³ãäœéãèœãšããããšã«ã€ããŠèª¬æããŠããŸããããžã ãªããæ°çããã¿ããã€ãšãããªããããŒãããã¢ã€ã¹ã¯ãªãŒã ããã¶ã諊ããã«ããšã®ããšã§ãâŠ
Read